首页> 外文期刊>Endocrine journal >High Prevalence of Vitamin D Deficiency in Japanese Female Patients with Graves' Disease
【24h】

High Prevalence of Vitamin D Deficiency in Japanese Female Patients with Graves' Disease

机译:日本女性Graves病患者中维生素D缺乏症的高患病率

获取原文
           

摘要

References(29) Cited-By(9) We reported previously that vitamin D deficiency is a causal mechanism of postoperative tetany in patients with Graves' disease. The aim of the present study was to determine the prevalence of vitamin D deficiency by reviewing serum 25(OH)D levels in 208 patients with Graves' disease (146 women, 62 men) during a 1 year period. Serum 25(OH)D levels were significantly lower (p0.001) in female Graves' patients (31.8±13.3nmol/l) than in male patients (41.3±15.0nmol/l). Vitamin D deficiency (defined as a serum 25(OH)D value below 25nmol/l) was found in 40% of female patients and in 18% of male patients (p0.005). There was a significant seasonal variation in the 25(OH)D concentrations in female patients [amplitude 6.38 (95% CI, 5.42-7.56)], with values below 25nmol/l found in 58% of female patients during the winter months. There were significant (p0.001) differences in serum 25(OH)D levels between age groups in the female patients. The concentrations were lowest in patients in their twenties (25.1±8.2nmol/l) and highest in patients in their fifties and sixties (43.2±13.7nmol/l). Serum 25(OH)D concentrations might be monitored in patients with Graves' disease during antithyroid drug therapy, and vitamin D and/or calcium supplements are recommended for patients with vitamin D deficiency.
机译:参考文献(29)Cited-By(9)我们先前曾报道维生素D缺乏是Graves病患者术后手足抽搐的原因。本研究的目的是通过回顾1年期间208名Graves病患者(146名女性,62名男性)的血清25(OH)D水平,确定维生素D缺乏症的患病率。女性Graves患者的血清25(OH)D水平显着低于男性(41.3±15.0nmol / l)(p <0.001)(31.8±13.3nmol / l)。在40%的女性患者和18%的男性患者中发现维生素D缺乏症(定义为血清25(OH)D值低于25nmol / l)(p <0.005)。女性患者的25(OH)D浓度存在明显的季节性变化[幅度6.38(95%CI,5.42-7.56)],在冬季,58%的女性患者的25(OH)D值低于25nmol / l。在女性患者中,不同年龄组的血清25(OH)D水平存在显着差异(p <0.001)。二十岁患者的血药浓度最低(25.1±8.2nmol / l),五十岁和六十岁患者的血药浓度最高(43.2±13.7nmol / l)。在抗甲状腺药物治疗期间可能会监测Graves病患者的血清25(OH)D浓度,建议对维生素D缺乏的患者推荐维生素D和/或钙补充剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号